Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Combination Immunotherapy + Chemotherapy for Head and Neck Cancer
Recruiting1 awardPhase 1
Saint Louis, Missouri
This trial is for adults with head and neck cancer or liver cancer who haven't responded to previous treatment or for whom no standard treatment exists. The goal is to see if combining different drugs can shrink tumors. The drugs being tested are antibodies that work in different ways against cancer. All participants will receive BI 765063 and ezabenlimab. One group will not receive any additional drugs while the other groups will receive BI 836880, cetuximab, or chemotherapy. The trial will monitor the size of the tumor and the health of the participants.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service